The results derived from assessment of myocardial fibroblasts supernatant and serum Galectin-3 levels, the indicator of fibrosis, were consistent with the differences in myocardial fibrosis among groups described above (Figure 5 and Figure 6). This evidence concerns the gene LGALS3 and Myocardial fibrosis.